Open access · OA
via Europe PMC
Glycemic dysregulation and cognitive impairment in aging adults: a cross-sectional study with amyloid biomarker correlation.
Rajalakshmi R, Ramya CM, Naaz R, Madhunapantula SV, Uthaiah CA, Salimath PV.
Frontiers in aging · 2026
Abstract
<h4>Background</h4>Type 2 Diabetes Mellitus (T2DM) is a rising health concern, particularly affecting the elderly population. Beyond its well-established metabolic consequences, growing evidence suggests a strong association between type 2 diabetes mellitus and cognitive decline. The core features of diabetes, viz., chronic hyperglycemia and insulin resistance (IR), not only contribute to the neurodegenerative changes in the brain but also promote the generation and accumulation of amyloid-β (a hallmark feature in Alzheimer's disease). These molecular changes triggered by T2DM play a pivotal role in the onset of cognitive damage. In this study, we have explored the interplay between glycemic status, cognitive performance, and plasma amyloid-β (Aβ) levels in an ageing population.<h4>Methodology</h4>A cross-sectional study was conducted among 396 individuals aged 51-80 years. Based on their HbA1c levels, the study participants were categorized into four glycemic groups: individuals without diabetes, individuals with prediabetes, individuals with diabetes, and individuals with uncontrolled diabetes. Cognitive function was evaluated using the Modified Mini-Mental State Examination (3MSE). Fasting glucose, insulin, Homeostatic Model Assessment (HOMA)-IR, lipid profiles, and plasma Aβ 1-40 and Aβ 1-42 were measured. Statistical analyses were carried out using Chi-square tests, logistic regression, Spearman correlation, and Receiver Operating Characteristic (ROC) curve analysis.<h4>Results</h4>A comparative assessment in the study revealed the prevalence of cognitive impairment across all glycemic groups, with 40.15% of participants overall affected. It was observed that the prevalence increased with the glycemic index, with 26.97% of individuals without diabetes affected, 35.92% of individuals with prediabetes, 55.03% of individuals with diabetes under control, and 70.91% of individuals with uncontrolled diabetes (p < 0.001). Logistic regression indicated progressively higher odds of cognitive impairment with worsening glycemic control (OR for individuals with uncontrolled diabetes ≈6.87, p < 0.001). Age and HbA1c were significantly inversely correlated with 3MS scores. Plasma Aβ 1-40 and Aβ 1-42 levels were elevated in individuals with diabetes groups, while the Aβ 1-42/Aβ 1-40 ratio was positively associated with cognitive performance. The ROC curve analysis of the logistic regression indicated an Area Under Curve (AUC) of 0.76, suggesting good predictive capability.<h4>Conclusion</h4>Impaired glycemic status was found to be strongly associated with increased cognitive decline, alongside altered amyloid biomarker profiles, in elderly populations. These findings suggest the heightened importance of metabolic homeostasis and also underscore the critical need for early metabolic interventions and cognitive screening in the individuals with diabetes to mitigate the risk of early neurodegeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fragi.2026.1696711
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
R, R., CM, R., R, N., SV, M., CA, U., & PV., S. (2026). Glycemic dysregulation and cognitive impairment in aging adults: a cross-sectional study with amyloid biomarker correlation. <em>Frontiers in aging</em>. https://doi.org/10.3389/fragi.2026.1696711
Vancouver
R R, CM R, R N, SV M, CA U, PV. S. Glycemic dysregulation and cognitive impairment in aging adults: a cross-sectional study with amyloid biomarker correlation. Frontiers in aging. 2026. doi:10.3389/fragi.2026.1696711.
BibTeX
@article{rajalakshmi2026Glycem,
title = {Glycemic dysregulation and cognitive impairment in aging adults: a cross-sectional study with amyloid biomarker correlation.},
author = {Rajalakshmi R and Ramya CM and Naaz R and Madhunapantula SV and Uthaiah CA and Salimath PV.},
journal = {Frontiers in aging},
year = {2026},
doi = {10.3389/fragi.2026.1696711},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Colorado, Denver 2016
Open access · US-GOV
Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment
npj Aging 2026
Open access · CC-BY
Frailty-related plasma metabolomic signatures predict long-term mortality risk and implicate systemic aging pathways: evidence from a prospective cohort study
PubMed 2024
Preprint · CC-BY
Prevalence of Hypertension and Type 2 Diabetes Mellitus among Patients with Metabolic Syndrome in Rural Southern Nigeria: Gender and Age Disparities
Diabetes Care 2016
Citation only
An Inverse Relationship Between Age of Type 2 Diabetes Onset and Complication Risk and Mortality: The Impact of Youth-Onset Type 2 Diabetes
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2020
Open access · CC-BY
Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
Primary care diabetes 2021
Open access · OA